Search

Timothy J Krieger

from Richmond, TX
Age ~67
Get Report
Also known as:
Timothy Joseph Krieger, Tim Krieger, Timothy J Kriger, Tj Krieger
Phone and address:
7702 Dovetail Ln, Richmond, TX 77407
Related to:
Km Krieger
Connected to:
Alex Krieger, 73Alexandra R Krieger, 33Amy M Krieger, 43Anita R Krieger, 72Anne M Krieger, 50Annie M Krieger, 114Arthur J Krieger, 71Brett C Krieger, 55Carol A Krieger, 65Cathy L Krieger, 61

Timothy Krieger Phones & Addresses

  • 7702 Dovetail Ln, Richmond, TX 77407
  • Houston, TX
  • 75 Bedford Ave, Lowell, MA 01854 (978) 459-4238
  • Pasadena, CA
  • Laurel, MD
  • Bedford, MA
  • Monrovia, CA

Work

Company: Armstrong Teasdale LLP Address:

Ranks

Licence: Virginia - Authorized to practice law Date: 1993

Specialities

Copyright Infringement • Trademark Infringement • Intellectual Property • Intellectual Property Litigation • Intellectual Property Services

Professional Records

Lawyers & Attorneys

Timothy Krieger Photo 1

Timothy Alan Krieger - Lawyer

View page
Licenses:
Virginia - Authorized to practice law 1993
Timothy Krieger Photo 2

Timothy Krieger - Lawyer

View page
Office:
Armstrong Teasdale LLP
Specialties:
Copyright Infringement
Trademark Infringement
Intellectual Property
Intellectual Property Litigation
Intellectual Property Services
ISLN:
918280853
Admitted:
2005
University:
Saint Louis University, B.A., 1995; University of Missouri - Columbia, B.S., 1997
Law School:
Washington University School of Law, J.D., 2005
Timothy Krieger Photo 3

Timothy Krieger - Lawyer

View page
Address:
Federal Reserve Bank Plaza
Phone:
(314) 552-6394 (Phone), (314) 552-7394 (Fax)
Work:
Thompson Coburn LLP, Associate
Specialties:
Business Law
Information Technology
Intellectual Property
Law School:
Washington University in St. Louis School of Law
Education:
Washington University in St. Louis School of Law, JD
University of Missouri, BS
Saint Louis University, BA
Links:
Website

Resumes

Resumes

Timothy Krieger Photo 4

Executive Director, Manufacturing At Agennix

View page
Location:
Houston, Texas Area
Industry:
Biotechnology
Timothy Krieger Photo 5

Timothy Krieger

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Timothy Krieger
TWIN CITIES ENERGY, LLC
4265 San Felipe St STE 1100, Houston, TX 77027
19555 Oak Grv Ave, Prior Lake, MN 55372

Publications

Us Patents

Antimicrobial Cationic Peptides And Formulations Thereof

View page
US Patent:
6835536, Dec 28, 2004
Filed:
Aug 20, 2002
Appl. No.:
10/225087
Inventors:
Timothy J. Krieger - Monrovia CA
Patricia J. McNicol - Vancouver, CA
Assignee:
Micrologix Biotech Inc. - Vancouver
International Classification:
C12Q 170
US Classification:
435 5, 435 72, 435325, 514 12, 514 13, 530324, 530326
Abstract:
Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device.

Compositions And Methods For Treating Infections Using Cationic Peptides Alone Or In Combination With Antibiotics

View page
US Patent:
7309759, Dec 18, 2007
Filed:
Oct 18, 2002
Appl. No.:
10/277233
Inventors:
Timothy J Krieger - Monrovia CA, US
Robert Taylor - White Rock, CA
Douglas Erfle - Vancouver, CA
Janet R Fraser - Vancouver, CA
Michael H P West - Caledon East, CA
Patricia J McNicol - Vancouver, CA
Assignee:
Migenix Inc. - Vancouver
International Classification:
A61K 38/00
A61K 49/00
A01N 37/18
C07K 5/00
C07K 7/00
C07K 16/00
C07K 17/00
US Classification:
530300, 530324, 530326, 530327, 530328, 514 2, 424 91
Abstract:
Compositions and methods for treating infections, especially bacterial infections, are provided. Indolicidin peptide analogues containing at least two basic amino acids are prepared. The analogues are administered as modified peptides, preferably containing photo-oxidized solubilizer.

Compositions And Methods For Treating Infections Using Analogues Of Indolicidin

View page
US Patent:
7390787, Jun 24, 2008
Filed:
Jan 24, 2003
Appl. No.:
10/351985
Inventors:
Janet R. Fraser - Vancouver, CA
Michael H. P. West - Caledon East, CA
Timothy J. Krieger - Monrovia CA, US
Robert Taylor - White Rock, CA
Douglas Erfle - Vancouver, CA
Assignee:
Migenix Inc. - Vancouver
International Classification:
A61K 38/00
A61K 49/00
C07K 7/00
US Classification:
514 14, 530327, 424 91
Abstract:
Compositions and methods for treating infections, especially bacterial infections, are provided. Indolicidin peptide analogues containing at least two basic amino acids are prepared. The analogues are administered as modified peptides, preferably containing photo-oxidized solubilizer.

Antimicrobial Cationic Peptides And Formulations Thereof

View page
US Patent:
8138144, Mar 20, 2012
Filed:
Jun 10, 2004
Appl. No.:
10/865687
Inventors:
Timothy J. Krieger - Lowell MA, US
Patricia J. McNicol - Vancouver, CA
Assignee:
Carrus Capital Corporation - Vancouver
International Classification:
A61K 38/04
US Classification:
514 2
Abstract:
Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device.

Antimicrobial Cationic Peptides And Formulations Thereof

View page
US Patent:
8466102, Jun 18, 2013
Filed:
Mar 15, 2012
Appl. No.:
13/421018
Inventors:
Timothy J. Krieger - Lowell MA, US
Patricia J. McNicol - Vancouver, CA
Assignee:
Carrus Capital Corporation - Vancouver
International Classification:
A61K 38/04
US Classification:
514 2
Abstract:
Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device.

Control Of Drug Release By Transient Modification Of Local Microenvironments

View page
US Patent:
20060171989, Aug 3, 2006
Filed:
Jan 25, 2006
Appl. No.:
11/339062
Inventors:
James Prescott - Cambridge MA, US
Timothy Krieger - Houston TX, US
Elizabeth Proos - Uxbridge MA, US
International Classification:
A61K 38/29
A61K 38/27
A61K 38/22
A61K 38/17
A61K 38/09
A61F 2/00
US Classification:
424426000, 514012000, 514015000
Abstract:
Methods, formulations, and devices are provided for enhancing drug delivery from a medical device. The method is provided for increasing the rate or quantity of a drug formulation released from an implantable drug delivery device, which method comprises the step of providing a release-modifying agent within or proximate to the implantable drug delivery device, in a manner effective to inhibit gelation, aggregation, or precipitation of the drug formulation being released from the device. The drug formulation and the release-modifying agent may be stored together in at least one reservoir in the implantable drug deliver device. Alternatively, the release-modifying agent may be stored in one or more reservoirs separate from the drug formulation.

Alpha 1-Antitrypsin Compositions And Treatment Methods Using Such Compositions

View page
US Patent:
20080312136, Dec 18, 2008
Filed:
Nov 11, 2004
Appl. No.:
10/579088
Inventors:
Manzer Durrani - Plantation FL, US
Harish Kumar - Fullerton CA, US
Timothy Krieger - Lowell MA, US
Ken Kabingue - Los Angeles CA, US
Virginia Mosher - Lebanon MO, US
Philip J. Barr - Oakland CA, US
Ian C. Bathurst - Breitenbach, AT
International Classification:
A61K 38/55
A61P 11/00
US Classification:
514 8
Abstract:
Alpha 1-antitrypsin compositions and treatment methods using such compositions for treating a variety of pulmonary diseases are provided. The compositions generally contain AAT, a stabilizing carbohydrate such as trehalose, a surfactant such as Polysorbate 80 and an antioxidant to stabilize AAT for use as a therapeutic. The formulations can be prepared as both liquids and solids and administered by nebulization of the liquid formulation or by conversion of dry powder formulation into an aerosol.

Control Of Drug Release By Transient Modification Of Local Microenvironments

View page
US Patent:
20090142386, Jun 4, 2009
Filed:
Feb 9, 2009
Appl. No.:
12/367900
Inventors:
James H. Prescott - Cambridge MA, US
Timothy Krieger - Houston TX, US
Elizabeth R. Proos - Westford MA, US
Assignee:
MICROCHIPS, INC. - Bedford MA
International Classification:
A61K 38/22
A61F 2/00
A61K 38/02
A61K 38/29
US Classification:
424423, 514 2, 514 12
Abstract:
Methods, formulations, and devices are provided for enhancing drug delivery from a medical device. The method is provided for increasing the rate or quantity of a drug formulation released from an implantable drug delivery device, which method comprises the step of providing a release-modifying agent within or proximate to the implantable drug delivery device, in a manner effective to inhibit gelation, aggregation, or precipitation of the drug formulation being released from the device. The drug formulation and the release-modifying agent may be stored together in at least one reservoir in the implantable drug deliver device. Alternatively, the release-modifying agent may be stored in one or more reservoirs separate from the drug formulation.
Control profile
Timothy J Krieger from Richmond, TX, age ~67 Get Report